NRX Pharmaceuticals Statistics
NASDAQ: NRXPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.85-0.051 (-1.76%)
Market open · Delayed 15 min · as of Oct 8, 9:55 AM ET
NRX Pharmaceuticals by the numbers
NRX Pharmaceuticals has a market capitalization of $123.3 million based on 43.30M shares outstanding. With trailing EPS of $-0.58, NRX Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.2% below its 50-day average and 3.4% below its 200-day average.
Average daily trading volume is 867.50K shares, or about $2.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NRXP valuation vs. peer median
| Metric | NRXP | Peer median | Difference |
|---|---|---|---|
| Market cap | $123.35M | $126.16M | -2% |
| Avg. volume | 867.50K | 163.89K | +429% |
Peer median across 8 companies: SPRB, BGM, HURA, CLLS, TNXP, VTVT, QUCY, OGI.
Valuation
- Market cap
- $123.35M
- EPS (TTM)
- $-0.58
- Shares outstanding
- 43.30M
Price and trading
- Previous close
- 2.90
- Open
- 2.88
- Day range
- 2.81 – 2.88
- 52-week range
- 1.62 – 5.06
- 52-week change
- -20.98%
- Beta
- —
- Volume
- 75.12K
- Average volume
- 867.50K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 123.35M
- Forward Pe
- -8.14
- Eps
- -0.58
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.06
- Week52 Low
- 1.62
- Avg Volume
- 867.50K
- Shares Outstanding
- 43.30M
- Ma50
- 3.28
- Ma200
- 2.95
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -43.64%
- Pct From52w Low
- 75.86%